| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTN4
|
actinin, alpha 4
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADGRV1
|
adhesion G protein-coupled receptor V1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR2
|
adiponectin receptor 2
|
|
ADM
|
adrenomedullin
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALAS1
|
5'-aminolevulinate synthase 1
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APOA2
|
apolipoprotein A-II
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ARVCF
|
armadillo repeat gene deleted in velocardiofacial syndrome
|
|
ASGR1
|
asialoglycoprotein receptor 1
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
AZIN1
|
antizyme inhibitor 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BICC1
|
BicC family RNA binding protein 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
BPIFB1
|
BPI fold containing family B, member 1
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BTLA
|
B and T lymphocyte associated
|
|
C19ORF48
|
chromosome 19 open reading frame 48
|
|
C2
|
complement component 2
|
|
C3
|
complement component 3
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMK2D
|
calcium/calmodulin-dependent protein kinase II delta
|
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma
|
|
CAPN10
|
calpain 10
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPNS1
|
calpain, small subunit 1
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASC15
|
cancer susceptibility candidate 15 (non-protein coding)
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CBX4
|
chromobox homolog 4
|
|
CBX8
|
chromobox homolog 8
|
|
CC2D2A
|
coiled-coil and C2 domain containing 2A
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD33
|
CD33 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC73
|
cell division cycle 73
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CENPO
|
centromere protein O
|
|
CETN2
|
centrin, EF-hand protein, 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIC
|
capicua transcriptional repressor
|
|
CILP2
|
cartilage intermediate layer protein 2
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CNTLN
|
centlein, centrosomal protein
|
|
COL17A1
|
collagen, type XVII, alpha 1
|
|
COL27A1
|
collagen, type XXVII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRISP3
|
cysteine-rich secretory protein 3
|
|
CRYGB
|
crystallin, gamma B
|
|
CRYGC
|
crystallin, gamma C
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CUL5
|
cullin 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP46A1
|
cytochrome P450, family 46, subfamily A, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DBI
|
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)
|
|
DCAF4
|
DDB1 and CUL4 associated factor 4
|
|
DCTN1
|
dynactin 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX39B
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DFNB31
|
deafness, autosomal recessive 31
|
|
DGKQ
|
diacylglycerol kinase, theta 110kDa
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
DHFR
|
dihydrofolate reductase
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DMD
|
dystrophin
|
|
DNASE1L1
|
deoxyribonuclease I-like 1
|
|
DPP7
|
dipeptidyl-peptidase 7
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DSG2
|
desmoglein 2
|
|
DSP
|
desmoplakin
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELOVL5
|
ELOVL fatty acid elongase 5
|
|
EPB41
|
erythrocyte membrane protein band 4.1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FADS3
|
fatty acid desaturase 3
|
|
FAN1
|
FANCD2/FANCI-associated nuclease 1
|
|
FBL
|
fibrillarin
|
|
FBN1
|
fibrillin 1
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGFR1OP2
|
FGFR1 oncogene partner 2
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FKBP5
|
FK506 binding protein 5
|
|
FKBP8
|
FK506 binding protein 8, 38kDa
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FOXA2
|
forkhead box A2
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FPGS
|
folylpolyglutamate synthase
|
|
FPR2
|
formyl peptide receptor 2
|
|
FTO
|
fat mass and obesity associated
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GAK
|
cyclin G associated kinase
|
|
GBA
|
glucosidase, beta, acid
|
|
GCG
|
glucagon
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GEMIN4
|
gem (nuclear organelle) associated protein 4
|
|
GGH
|
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA5
|
gap junction protein, alpha 5, 40kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNAS
|
GNAS complex locus
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPR151
|
G protein-coupled receptor 151
|
|
GPX1
|
glutathione peroxidase 1
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO1
|
glutathione S-transferase omega 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GUCA1B
|
guanylate cyclase activator 1B (retina)
|
|
GYPA
|
glycophorin A (MNS blood group)
|
|
HBB
|
hemoglobin, beta
|
|
HBS1L
|
HBS1-like translational GTPase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC4
|
histone deacetylase 4
|
|
HFE
|
hemochromatosis
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HMGB1
|
high mobility group box 1
|
|
HMHA1
|
histocompatibility (minor) HA-1
|
|
HMHB1
|
histocompatibility (minor) HB-1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB7
|
heat shock 27kDa protein family, member 7 (cardiovascular)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDUA
|
iduronidase, alpha-L-
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL13
|
interleukin 13
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL19
|
interleukin 19
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL3
|
interleukin 3
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IQCB1
|
IQ motif containing B1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRGM
|
immunity-related GTPase family, M
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK2
|
Janus kinase 2
|
|
JMY
|
junction mediating and regulatory protein, p53 cofactor
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD10
|
potassium channel tetramerization domain containing 10
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0020
|
KIAA0020
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLF7
|
Kruppel-like factor 7 (ubiquitous)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KPNA2
|
karyopherin alpha 2 (RAG cohort 1, importin alpha 1)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LTA
|
lymphotoxin alpha
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK8IP1
|
mitogen-activated protein kinase 8 interacting protein 1
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC3R
|
melanocortin 3 receptor
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGP
|
matrix Gla protein
|
|
MLH1
|
mutL homolog 1
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUTYH
|
mutY homolog
|
|
MVK
|
mevalonate kinase
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYO9B
|
myosin IXB
|
|
MZF1
|
myeloid zinc finger 1
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NDOR1
|
NADPH dependent diflavin oxidoreductase 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIL1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1
|
|
NFYA
|
nuclear transcription factor Y, alpha
|
|
NFYB
|
nuclear transcription factor Y, beta
|
|
NFYC
|
nuclear transcription factor Y, gamma
|
|
NME8
|
NME/NM23 family member 8
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH4
|
notch 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPPA
|
natriuretic peptide A
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRF1
|
nuclear respiratory factor 1
|
|
NRP1
|
neuropilin 1
|
|
NTNG1
|
netrin G1
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
OPN4
|
opsin 4
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OTC
|
ornithine carbamoyltransferase
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PAX6
|
paired box 6
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDE8B
|
phosphodiesterase 8B
|
|
PDLIM5
|
PDZ and LIM domain 5
|
|
PDYN
|
prodynorphin
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PGR
|
progesterone receptor
|
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PIP4K2A
|
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
|
|
PITX3
|
paired-like homeodomain 3
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLIN1
|
perilipin 1
|
|
PLSCR4
|
phospholipid scramblase 4
|
|
PNPLA2
|
patatin-like phospholipase domain containing 2
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POLK
|
polymerase (DNA directed) kappa
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme
|
|
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRDM9
|
PR domain containing 9
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKD1
|
protein kinase D1
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROS1
|
protein S (alpha)
|
|
PRPF31
|
pre-mRNA processing factor 31
|
|
PSEN2
|
presenilin 2
|
|
PSMA6
|
proteasome (prosome, macropain) subunit, alpha type, 6
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTGES2
|
prostaglandin E synthase 2
|
|
PTMA
|
prothymosin, alpha
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRCAP
|
protein tyrosine phosphatase, receptor type, C-associated protein
|
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C)
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RECQL4
|
RecQ protein-like 4
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RETN
|
resistin
|
|
RHOB
|
ras homolog family member B
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNPC3
|
RNA-binding region (RNP1, RRM) containing 3
|
|
RNU4ATAC
|
RNA, U4atac small nuclear (U12-dependent splicing)
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPGRIP1L
|
RPGRIP1-like
|
|
S100A10
|
S100 calcium binding protein A10
|
|
S100B
|
S100 calcium binding protein B
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SERPINA12
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SLK
|
STE20-like kinase
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SMPD1
|
sphingomyelin phosphodiesterase 1, acid lysosomal
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNCB
|
synuclein, beta
|
|
SNRNP48
|
small nuclear ribonucleoprotein 48kDa (U11/U12)
|
|
SOAT1
|
sterol O-acyltransferase 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOST
|
sclerostin
|
|
SP110
|
SP110 nuclear body protein
|
|
SPG11
|
spastic paraplegia 11 (autosomal recessive)
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
ST8SIA5
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STK11
|
serine/threonine kinase 11
|
|
SUV39H2
|
suppressor of variegation 3-9 homolog 2 (Drosophila)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAZ
|
tafazzin
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TERC
|
telomerase RNA component
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM67
|
transmembrane protein 67
|
|
TMSB4Y
|
thymosin beta 4, Y-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TOMM70A
|
translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPI1
|
triosephosphate isomerase 1
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM21
|
tripartite motif containing 21
|
|
TRIM5
|
tripartite motif containing 5
|
|
TROVE2
|
TROVE domain family, member 2
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UMOD
|
uromodulin
|
|
UPK3A
|
uroplakin 3A
|
|
USH1G
|
Usher syndrome 1G (autosomal recessive)
|
|
VAMP7
|
vesicle-associated membrane protein 7
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDAC2
|
voltage-dependent anion channel 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIMP
|
VCP-interacting membrane selenoprotein
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VSX1
|
visual system homeobox 1
|
|
VWF
|
von Willebrand factor
|
|
WDR36
|
WD repeat domain 36
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT6
|
wingless-type MMTV integration site family, member 6
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
YBX1
|
Y box binding protein 1
|
